Novo Nordisk's (NVO) corrections amid AI market rotation might be an opportunity, due to GLP-1 market leadership & balanced ...

T-Mobile debuts investment-grade baby bonds (TMUSZ, TMUSL, TMUSI) maturing 2069–2070. Explore yields up to 6.22% and strong ...

The real assets portfolio was the primary detractor due to negative returns for energy stocks and U.S. real estate investment ...

Afya's Q2 2025 results were solid, but the stock faces headwinds from market saturation and regulatory changes in Brazil's ...

Tonix's Tonmya received FDA approval, marking the first new fibromyalgia therapy in 15 years and driving a post-market stock ...

IHF offers exposure to large-cap healthcare, AI-driven growth, and demographic trends, with a recent dip creating a strong ...

I've made costly mistakes in my REIT investing journey, lessons that reshaped my approach and strategy. Learn why smarter ...

Healthcare Opportunities Fund offers a compelling way to play the healthcare sector. Read here for an analysis of THQ CEF.

Novo Nordisk (NVO) stock in focus as the company wins FDA accelerated nod for weight loss therapy Wegovy against the liver ...

Powell Industries (POWL) offers 50% upside potential. Learn about growth in Electric Utility, strategic acquisitions, and ...

Value Line's digital growth offsets print decline, ensuring steady dividends amid modest revenue. Read here for an analysis ...

Hope Bancorp's loan growth outlook in markets in Hawaii, California, and New York is slightly negative. See why a hold rating ...